Fattal Europe in the first quarter: Partnership IV brings the capital test back to the front
Fattal Europe is close to ending the investment phase of Partnership III, but it is already preparing another vehicle where its expected share may reach EUR 150-200 million. The quarter shows that the institutional partnership model works, but also that it requires continuous access to debt, asset refinancing and parent support before the new NOI can carry the model on its own.
Fattal Europe opened 2026 with a quarter that puts the strength and weakness of its partnership model on the same page. On the positive side, hotels acquired in 2025 are already lifting rental income, operating cash flow improved, and the company continues to show access to the bond market and bank financing. On the other side, the third partnership still consumed about EUR 30 million of cash in the quarter, the company is already working on a new and larger partnership, and the gap between asset growth and free cash remains wide. This is why the quarter is not only a story of rising NOI against weak FFO, which is the first read of the filing. It sharpens a deeper question: is the company turning institutional capital into a growth multiplier that lowers risk, or is it building a machine that needs more refinancing cycles before the current assets can carry themselves. The current evidence sits in the middle. The model works for buying assets and keeping funding channels open, but it has not yet proven full cash independence. The next proof points are the end of Partnership III's investment phase, the pace of 2026 refinancing, and whether Partnership IV can be formed without increasing reliance on the parent company and the bond market again.
The real growth engine sits in the partnerships, not only in consolidated hotels
Fattal Europe is an income-producing hotel real-estate company in Europe, but reading the filing only through the number of hotels misses the economic structure. As of the signing date, it held 117 hotels including future hotels, of which 111 were active. 55 hotels are leased to subsidiaries of the parent company, and another 51 are managed by subsidiaries of the parent company. That makes the company a bond issuer holding hotel assets, but also a machine that expands exposure through institutions, partnerships and capital calls.
The new point this quarter is not another single hotel acquisition. Partnership III has already signed transactions to buy 36 hotels in the Netherlands, France, Spain, Italy, Germany, Ireland, England, Greece and Austria. The company's share of the partnership's investment commitment is EUR 158.8 million, of which about EUR 106 million had already been invested as of the signing date. The company expects the investment period of this partnership to end during the second quarter of 2026.
At the same time, the company is already working to establish another hotel partnership with institutional investors. The new partnership's total equity is expected to range from EUR 600 million to EUR 1 billion, and the company's investment share is expected to be EUR 150-200 million. This is not a fully drawn commitment today, but it is a clear direction: before the third partnership has finished being built, the company is already pointing to the next capital cycle.
| Growth vehicle | First-quarter status | Company share or exposure | Economic meaning |
|---|---|---|---|
| Partnership II | About EUR 97 million invested out of a EUR 100 million commitment | Almost the full commitment | This stage is close to maturity and can be tested through capital returns and cash flow |
| Partnership III | About EUR 106 million invested out of a EUR 158.8 million commitment | Possible remaining amount of about EUR 52.8 million | There is still an equity requirement before the investment period ends |
| Partnership IV | The company is working to establish it with institutions | Expected company share of EUR 150-200 million | The next growth engine could be larger than the remaining equity need in Partnership III |
The table explains why this quarter matters. Fattal Europe's model is not just buying, leasing and holding. It is a continuous movement between three layers: raising institutional capital, buying hotels, and then trying to turn those assets into NOI, FFO, capital returns or refinancing capacity. If that movement works, the company gets a powerful growth lever without funding every deal by itself. If it runs too fast, the partnerships shift from equity-lightening vehicles into recurring users of capital.
Growth reaches NOI, but cash still needs funding
Rental income totaled EUR 18.464 million in the first quarter, compared with EUR 14.301 million in the parallel quarter, mainly because of new hotels in England acquired during 2025. Gross profit rose to EUR 18.018 million, and NOI reached EUR 17.390 million compared with EUR 13.805 million. At the asset level, this shows that the 2025 acquisitions were not only balance-sheet expansion. They are beginning to enter the operating line.
The same quarter also shows the cost. Net finance expenses rose to EUR 13.158 million, compared with EUR 7.829 million in the parallel quarter, mainly because of the bond issuance at the end of the first quarter of 2025, later expansions and new loans used to finance hotels acquired in 2025. FFO under management's approach fell to EUR 2.181 million, compared with EUR 4.280 million in the parallel quarter. The rise in NOI is therefore still not flowing cleanly to the bondholder and shareholder layer.
This is exactly why the earlier analysis of Partnerships II and III still matters. The partnerships reduce the equity the company needs to put into each transaction, but they do not eliminate the need for funding. In the first quarter, the investment in Partnership III was almost 14 times management-approach FFO. That does not make the investment problematic by itself. It means the growth story is currently measured by access to capital no less than by asset profitability.
Operating cash flow totaled EUR 18.070 million in the first quarter, compared with EUR 13.932 million in the parallel quarter. That is a real strength. But the all-in cash picture, meaning cash after actual investments, interest, repayments and debt raising, still depends on funding. The company invested EUR 30.495 million in equity-accounted companies and partnerships, mainly Partnership III, and paid EUR 15.314 million of interest. Against that, the expansion of Series F bonds brought in EUR 78.663 million, while the company repaid EUR 31.578 million of the parent-company loan and EUR 9.846 million of bonds.
The important number here is not the increase in ending cash, but how it was built. Operating activity alone did not fund investments, interest and repayments. It provided a base, but the flexibility came from the Series F bond expansion and from the ability to reduce the parent-company debt without emptying the cash balance. The company therefore looks more liquid after the quarter, but not more independent.
The hedging layer tells a similar story. In February 2026 the company expanded Series F bonds by about NIS 289.5 million, or about EUR 78 million, at a fixed shekel rate of 5.59% and with no linkage. During the period it entered into another hedge that converted shekel debt into euro exposure, but after that transaction about NIS 375 million of bonds remained unhedged. This does not change the whole thesis, but it is a reminder that Israeli funding for European assets creates a currency layer that still has to be managed.
The working-capital deficit is also a possible funding source, not only a pressure sign
The consolidated working-capital deficit stood at about EUR 135 million. The company argues that this does not indicate a liquidity problem, and its breakdown shows why that view is reasonable but not sufficient by itself. About EUR 50 million of the deficit relates to the final repayment of Series D bonds at the end of September 2026, against pledged assets valued at about EUR 163 million. Another EUR 78 million relates to loans against 13 hotels in Germany and the Netherlands, at about 34% LTV, which the company has begun refinancing with banks at an average LTV of about 60%.
That gap matters because it is not only debt that has to be repaid. If the refinancing closes as the company targets, part of the deficit can become a source of new cash. In addition, the company has 6 unpledged fully owned assets worth about EUR 41 million, and additional assets worth about EUR 92 million at an average LTV of about 36%, for which it is working to raise new external financing at an average LTV of about 65%. Above all that, there is an unused parent-company credit line of about EUR 92 million.
The balanced read is that the company does not look close to an immediate liquidity problem. Its equity-to-assets ratio is 37.17%, all bond series comply with their financial covenants, and Midroog rates the series A2.il with a stable outlook. But if Partnership IV advances, the funding test will no longer remain only a 2026 refinancing question. It will become broader: can the company refinance existing debt, keep investing through partnerships and reduce reliance on the parent company at the same time.
Three proof points for the coming half year
The next quarters need to show whether 2026 is a bridge year or the beginning of a new investment cycle. A bridge year means the company finishes Partnership III's investments, refinances the 2026 debt wall, and releases some assets into new financing without creating deeper reliance on the parent company. A new investment cycle means Partnership IV starts moving forward before FFO and capital returns from the existing partnerships are enough to carry the new requirements.
The first trigger is the end of Partnership III's investment period. If the company remains close to EUR 106 million invested out of EUR 158.8 million and starts seeing a stronger contribution from the acquired assets, the partnership will look like a vehicle reaching maturity. If capital calls continue without parallel improvement in FFO or capital returns, the model will look heavier.
The second trigger is debt and asset refinancing. The company discusses refinancing 13 hotels in Germany and the Netherlands at an average LTV of about 60%, and raising new debt against additional assets at an LTV of about 65%. These numbers can turn low-leverage assets into cash. They can also lift economic leverage if the new capital is used mainly for additional investments rather than easing pressure.
The third trigger is Partnership IV. At this stage the disclosure is still early, so it should not be treated as if the vehicle has already been formed and funded. But the company's expected EUR 150-200 million share is large enough to change the screen: it is almost three to four times the possible amount still remaining in Partnership III. That is why the new partnership already belongs in the quarter's thesis, even if not yet in the income statement.
Conclusion
The current conclusion is that Fattal Europe continues to prove access to capital and assets, but has not finished proving that this growth creates comfortable surplus cash at the issuer level. The quarter delivers good NOI data, preserves wide covenant headroom, and shows that the company can issue bonds, refinance assets and use parent support in a relatively controlled way. Still, the investment in Partnership III, the decline in management-approach FFO and the intention to establish another partnership make the capital test more important than the accounting profit test.
The counter-thesis is strong: the partnerships may actually reduce risk, because institutional investors fund most of the equity, the company benefits from a larger asset base, and the LTV of assets being refinanced remains low. That is true, but only if external capital keeps arriving on time and at reasonable cost, and if the acquired assets start returning cash at a pace that reduces the need for new capital calls. Partnership IV is therefore not only a growth opportunity. It is a test of whether the partnership model already creates a self-funding capital cycle, or still needs external fuel in every round.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.